According to clients, "Mr. Gianasso is very transaction-driven and very efficient. He knows us well as clients and really makes things easy for us, especially in the negotiations."

 

Chambers Europe 2020

Gaëtan Gianasso

London | Paris
  • 99 Bishopsgate
  • London EC2M 3XF
  • United Kingdom
 
 

Gaëtan Gianasso is a partner in the London and Paris offices of Latham & Watkins. Mr. Gianasso specializes in mergers and acquisitions and private equity with particular expertise in leveraged acquisitions (LBO). He has considerable experience representing private equity institutions in connection with acquisitions, dispositions, and transaction financing.

Recognitions

Mr. Gianasso is named in The Legal 500 EMEA 2020.

Mr. Gianasso advises a combination of asset management companies and private equity houses on high-value LBO deals both in France and abroad, with particular experience in Italy, Canada and the UK. Chambers Europe 2019

Mr. Gianasso has significant experience in the private equity sphere, including in high-end LBO transactions. Clients are impressed by his service, with one interviewee enthusing: 'He has a very strong understanding of all issues and he offers commercial solutions.'” Chambers Europe 2018

Mr. Gianasso is praised by clients for his “great technical skills" and is recognized as "a fine negotiator" (The Legal 500 EMEA 2016) as well as a leader in private equity. (The Legal 500 EMEA 2017 / Chambers Europe 2018) Clients also commend Mr. Gianasso as "well known in the growth capital market and in the private equity industry more broadly. He is technically very strong, and is excellent in helping clients get a transaction closed. He is very skilled in negotiations. He is also able to work both on minority and majority transactions. He is a pleasure to work with. We rate him extremely highly.” (Chambers Europe 2017)

Mr. Gianasso's recent experience includes advising:

Large Cap Transactions
  • Ardian in the acquisition of Cérélia (leading transatlantic provider of innovative bakery solutions) from IK Investment Partners (2019)
  • Platinum Equity in the acquisition of Biscuit International (leading European manufacturer of private label sweet biscuits) from Qualium Investissement (2019)
  • Cobepa in the sale of its stake in Staci (logistics solutions provider for companies) to Ardian (2019)
  • TA Associates in the sale of Hana Group (global provider of freshly prepared sushi “on the go”) to Permira (2019)
  • Ardian in the acquisition of a majority stake in DRT (development of rosin and turpentine extracted from pine resin) alongside Tikehau Capital (2018)
  • Ardian in the sale of SIACI Saint Honoré (insurance broking and employee benefits services) (2018)
  • Ardian in the sale of Trescal (calibration and measurement service solutions) (2018)
  • PSP Investments alongside CDPQ as part of a minority investment in Groupe Fives (industrial engineering) (2018)
  • PSP Investments in connection with the acquisition of Cerba Healthcare (medical biology laboratories) alongside Partners Group (2017)
  • Intermediate Capital Group (ICG) in connection with the acquisition of Domus Vi (retirement homes) (2017)
  • Onex in connection with the potential acquisition of Alvest and Albea Packaging (2017)
  • Ardian in connection with the sale of Novacap (production and sales of chemicals) to Eurazeo (2016)
  • Blackstone in connection with the potential acquisition of Verallia (food glass packaging) (2015)
  • Ardian in the acquisition of Photonis (manufacturer of photomultiplier tubes) (2011)
Mid Cap Transactions   
  • TA Associates in the sale of its minority stake in ZADIG & VOLTAIRE (French modern luxury ready-to-wear) to Peninsula (2020)
  • Ardian in the acquisition of a majority stake in the Santé Cie Group (specialist in home medical assistance) (2020)
  • DomusVi in the acquisition of HPA, the parent company of the Residalya group from Ackermans & van Haaren (flats and nursing homes for elderly people) (2019)
  • TA Associates in connection with a minority investment in Solabia (cosmetics, pharmaceuticals, and biotechnology) (2018)
  • Ardian and Hypred in connection with the acquisition of Anti-Germ International (development of disinfectants for the agricultural and food industries) (2017)
  • Cobepa in connection with the acquisition of Staci (retail logistics) (2017)

 

 
 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.